{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:43:01Z","timestamp":1792694581201,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","award":["NTU-110-A-CC-5400-64841"],"award-info":[{"award-number":["NTU-110-A-CC-5400-64841"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2113-M-002 -010 -MY3"],"award-info":[{"award-number":["NSTC 113-2113-M-002 -010 -MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jlr.2025.100955","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:06:02Z","timestamp":1764979562000},"page":"100955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dysregulated metabolism of ceramides and glycosphingolipids in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"67","author":[{"given":"Yu-Fong","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-0360","authenticated-orcid":false,"given":"Ching-Hua","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2025.100955_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jlr.2025.100955_bib2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jlr.2025.100955_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson's disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jlr.2025.100955_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2025.100955_bib5","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1093\/brain\/awac176","article-title":"Lipid pathway dysfunction is prevalent in patients with Parkinson's disease","volume":"145","author":"Galper","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2025.100955_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073094","article-title":"Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study","volume":"8","author":"Mielke","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2025.100955_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","article-title":"Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson\u2019s disease","volume":"14","author":"Huebecker","year":"2019","journal-title":"Mol. Neurodegener"},{"key":"10.1016\/j.jlr.2025.100955_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172348","article-title":"Elevated GM3 plasma concentration in idiopathic Parkinson's disease: a lipidomic analysis","volume":"12","author":"Chan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2025.100955_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.107071","article-title":"Plasma sphingolipids, dopaminergic degeneration and clinical progression in idiopathic Parkinson's disease","volume":"126","author":"Yang","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jlr.2025.100955_bib10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mds.28846","article-title":"Plasma glucosylsphingosine in GBA1 mutation carriers with and without Parkinson's disease","volume":"37","author":"Surface","year":"2022","journal-title":"Mov Disord."},{"key":"10.1016\/j.jlr.2025.100955_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2016.09.028","article-title":"Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson's disease dementia","volume":"370","author":"Xing","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jlr.2025.100955_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279315","article-title":"Plasma sphingolipid abnormalities in neurodegenerative diseases","volume":"17","author":"Oizumi","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2025.100955_bib13","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/mds.28186","article-title":"High glucosylceramides and low anandamide contribute to sensory loss and pain in Parkinson's disease","volume":"35","author":"Klatt-Schreiner","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jlr.2025.100955_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/metabo13090990","article-title":"Serum-based lipid panels for diagnosis of idiopathic Parkinson's disease","volume":"13","author":"Dahabiyeh","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.jlr.2025.100955_bib15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jlr.2025.100955_bib16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jlr.2025.100955_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/brain\/awz350","article-title":"Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and lewy body dementia","volume":"143","author":"Blauwendraat","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2025.100955_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2018.01.012","article-title":"Alpha galactosidase A activity in Parkinson's disease","volume":"112","author":"Alcalay","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jlr.2025.100955_bib19","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1038\/s41467-025-59755-6","article-title":"Extended coverage of human serum glycosphingolipidome by 4D-RP-LC TIMS-PASEF unravels association with Parkinson's disease","volume":"16","author":"Vo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jlr.2025.100955_bib20","doi-asserted-by":"crossref","first-page":"20945","DOI":"10.1038\/s41598-021-00404-5","article-title":"Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model","volume":"11","author":"Viel","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jlr.2025.100955_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jlr.2025.100955_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.jlr.2025.100955_bib23","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord."},{"key":"10.1016\/j.jlr.2025.100955_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jlr.2025.100955_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab535","article-title":"TIGER: technical variation elimination for metabolomics data using ensemble learning architecture","volume":"23","author":"Han","year":"2022","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.jlr.2025.100955_bib26","doi-asserted-by":"crossref","first-page":"W390","DOI":"10.1093\/nar\/gkae335","article-title":"LipidSig 2.0: integrating lipid characteristic insights into advanced lipidomics data analysis","volume":"52","author":"Liu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jlr.2025.100955_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5334\/jors.431","article-title":"Plots.jl \u2013 a user extendable plotting API for the Julia programming Language","volume":"11","author":"Christ","year":"2023","journal-title":"J. Open Res. Softw."},{"key":"10.1016\/j.jlr.2025.100955_bib28","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets-update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jlr.2025.100955_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41582-024-00999-z","article-title":"Gaucher disease provides a unique window into Parkinson disease pathogenesis","volume":"20","author":"Hertz","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jlr.2025.100955_bib30","doi-asserted-by":"crossref","first-page":"16955","DOI":"10.1021\/acs.analchem.4c04094","article-title":"Selective enrichment via TiO magnetic nanoparticles enables deep profiling of circulating neutral glycosphingolipids","volume":"96","author":"Wang","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jlr.2025.100955_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.342144","article-title":"HILIC\/MS quantitation of low-abundant phospholipids and sphingolipids in human plasma and serum: dysregulation in pancreatic cancer","volume":"1288","author":"Peterka","year":"2024","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jlr.2025.100955_bib32","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00216-021-03853-z","article-title":"A simple and rapid method for extraction and measurement of circulating sphingolipids using LC-MS\/MS: a targeted lipidomic analysis","volume":"414","author":"Xu","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jlr.2025.100955_bib33","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"Pt 3","key":"10.1016\/j.jlr.2025.100955_bib34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","article-title":"Reduced glucocerebrosidase is associated with increased \u03b1-synuclein in sporadic Parkinson's disease","volume":"137","author":"Murphy","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2025.100955_bib35","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27136","article-title":"Cerebrospinal fluid \u03b2-glucocerebrosidase activity is reduced in Parkinson'S disease patients","volume":"32","author":"Parnetti","year":"2017","journal-title":"Mov Disord."},{"issue":"Pt 9","key":"10.1016\/j.jlr.2025.100955_bib36","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2025.100955_bib37","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/mds.29360","article-title":"A biomarker study in patients with GBA1-Parkinson's disease and healthy controls","volume":"38","author":"den Heijer","year":"2023","journal-title":"Mov Disord."},{"key":"10.1016\/j.jlr.2025.100955_bib38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1194\/jlr.D089797","article-title":"DMS as an orthogonal separation to LC\/ESI\/MS\/MS for quantifying isomeric cerebrosides in plasma and cerebrospinal fluid[S]","volume":"60","author":"Xu","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jlr.2025.100955_bib39","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/ajcp\/60.6.890","article-title":"Galactosylceramides in human plasma","volume":"60","author":"Wells","year":"1973","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jlr.2025.100955_bib40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.26278","article-title":"No evidence for substrate accumulation in Parkinson brains with mutations","volume":"30","author":"Gegg","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jlr.2025.100955_bib41","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1021\/acsnano.1c02957","article-title":"Glucosylceramide associated with gaucher disease forms amyloid-like twisted ribbon fibrils that induce \u03b1-Synuclein aggregation","volume":"15","author":"Paul","year":"2021","journal-title":"ACS Nano."},{"key":"10.1016\/j.jlr.2025.100955_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-Synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli Joseph","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jlr.2025.100955_bib43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41531-023-00517-w","article-title":"Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson\u2019s disease","volume":"9","author":"Leyns","year":"2023","journal-title":"NPJ Parkinson's Dis."},{"key":"10.1016\/j.jlr.2025.100955_bib44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41580-024-00742-y","article-title":"Regulation of cellular and systemic sphingolipid homeostasis","volume":"25","author":"Kuo","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jlr.2025.100955_bib45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.nbd.2017.11.006","article-title":"The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein","volume":"110","author":"Nelson","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jlr.2025.100955_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12993-025-00289-8","article-title":"C18:0 GM3 ganglioside's efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation","volume":"21","author":"Liu","year":"2025","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.jlr.2025.100955_bib47","doi-asserted-by":"crossref","first-page":"116108","DOI":"10.1016\/j.ejmech.2023.116108","article-title":"Synthesis, biological activity evaluation and mechanism analysis of new ganglioside GM3 derivatives as potential agents for nervous functional recovery","volume":"266","author":"Lin","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jlr.2025.100955_bib48","doi-asserted-by":"crossref","first-page":"106934","DOI":"10.1016\/j.bpc.2022.106934","article-title":"Ganglioside GM3 stimulates lipid-protein co-assembly in ?-synuclein amyloid formation","volume":"293","author":"Fridolf","year":"2023","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jlr.2025.100955_bib49","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jmb.2011.03.009","article-title":"Molecular basis for the glycosphingolipid-binding specificity of \u03b1-Synuclein: key role of tyrosine 39 in membrane insertion","volume":"408","author":"Fantini","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jlr.2025.100955_bib50","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/acn3.51856","article-title":"Enzymatic properties and clinical associations of serum alpha-galactosidase A in Parkinson's disease","volume":"10","author":"Mizutani","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jlr.2025.100955_bib51","doi-asserted-by":"crossref","first-page":"17755","DOI":"10.1016\/S0021-9258(19)77900-9","article-title":"Man, apes, and old-world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells","volume":"263","author":"Galili","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100955_bib52","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1016\/S0021-9258(20)89600-8","article-title":"Characterization of an Alpha-1-]3-Galactosyltransferase homolog on human Chromosome-12 that is organized as a processed pseudogene","volume":"266","author":"Joziasse","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100955_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","article-title":"Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide","volume":"109","author":"De Francesco","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jlr.2025.100955_bib54","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/mds.29204","article-title":"The sphingolipids clearly play a role in Parkinson's Disease, but nature has made it complicated","volume":"37","author":"Lansbury","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jlr.2025.100955_bib55","doi-asserted-by":"crossref","first-page":"9931","DOI":"10.1073\/pnas.0811269106","article-title":"Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities (vol 106, pg 8186, 2009)","volume":"106","author":"Han","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2025.100955_bib56","doi-asserted-by":"crossref","first-page":"13397","DOI":"10.1074\/jbc.M112.428185","article-title":"Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties","volume":"288","author":"Russo","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jlr.2025.100955_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-3-030-21162-2_4","article-title":"A stroll Down the CerS Lane","volume":"1159","author":"Zelnik","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jlr.2025.100955_bib58","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1096\/fj.201700300R","article-title":"Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes","volume":"32","author":"Law","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.jlr.2025.100955_bib59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41531-025-00960-x","article-title":"The role of alpha-synuclein in synucleinopathy: impact on lipid regulation at mitochondria\u2013ER membranes","volume":"11","author":"Barbuti","year":"2025","journal-title":"NPJ Parkinson's Dis."},{"key":"10.1016\/j.jlr.2025.100955_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaf133","article-title":"Alpha-synuclein aggregation induces prominent cellular lipid changes as revealed by Raman spectroscopy and machine learning analysis","volume":"7","author":"Coles","year":"2025","journal-title":"Brain Commun."},{"issue":"447","key":"10.1016\/j.jlr.2025.100955_bib61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41587-023-01690-2","article-title":"Integrative analysis of multimodal mass spectrometry data in MZmine 3","volume":"41","author":"Schmid","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jlr.2025.100955_bib62","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13321-017-0205-3","article-title":"Comprehensive identification of sphingolipid species by in silico retention time and tandem mass spectral library","volume":"9","author":"Tsugawa","year":"2017","journal-title":"J Cheminformatics"}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525002184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227525002184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:29:37Z","timestamp":1789082977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227525002184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0022227525002184"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100955","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated metabolism of ceramides and glycosphingolipids in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2025.100955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100955"}}